Zydus Lifesciences Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 1 B, PHARMEZ Special Economic Zone, Sarkhej Bavla N.H.No. 8A, Matoda, Tal.: Sanand, Ahmedabad, Gujarat 382213, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3008957483 · DUNS 650461283
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-07-19
- NAIDrug Quality Assurance2015-05-13
- VAIDrug Quality Assurance2013-09-21
Drugs this plant is listed as making
2 distinct drugs across 10 products name this site in their FDA label.
- RivastigmineZydus Pharmaceuticals USA Inc.
- ScopolamineZydus Pharmaceuticals USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.